InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,107.20
(
-1.02%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.66
(
-0.15%
)
Bitcoin
66,071.09
(
0.22%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gdollasign

Send PM Follow Ignore
Followers 6
Posts 973
Boards Moderated 0
Alias Born 06/08/2010

gdollasign

Re: Jesspro post# 49100

Friday, 05/09/2014 11:49:42 AM

Friday, May 09, 2014 11:49:42 AM

Post# of 80490
Denner isnt the only one. Proven guys like Hugh Cole wouldnt leave a seemingly great position at Shire to come to a company with no future.

To me Iclusig in CML is a lost opportunity and should be discounted entirely as a viable revenue stream. No sense in beating a dead horse. Iclusig in other indications and 113 will take time to play out. Not everyone can afford to wait 2 years but I would bet my last dollar that both drugs will find their way.


G$



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up